CEM confirms effectiveness of cryoablation

CHICAGO -- Contrast-enhanced mammography (CEM) confirms the effectiveness of ultrasound-guided cryoablation and could serve as a reliable annual follow-up exam, findings presented November 26 at the RSNA annual meeting suggest. In her presentation, Federica di Naro, MD, from Azienda Ospedaliero-Universitaria Careggi in Florence, Italy discussed her team’s results, which showed that combining CEM and re-evaluation with biopsy in selected breast cancer histology proves the efficacy of ultrasound-guided cryoabaltion and CEM’s reliability.“CEM is a valuable tool to define the effectiveness of cryoablation,” di Naro said. Cryoablation is a minimally invasive treatment option that sees targeted tissues killed by extreme cold, using ultrasound guidance. Di Nara noted that this is a useful alternative for elderly women not eligible for surgery. She added that CEM is also a useful imaging modality for elderly women who may struggle to stay still or maintain specific positions needed for MRI.Di Nara and colleagues wanted to find out whether ultrasound-guided cryoablation could be effective in treating low-risk early-stage breast cancer, combining CEM and re-evaluation with biopsy.For the study, the team included data from cryoablation data from 28 biopsy-proven malignant lesions in 28 patients with an average age of 73.4 years. The patients were held inoperable by a multidisciplinary group, under hormone therapy. The team reported that all lesions were ultrasound-visible invasi...
Source: AuntMinnie.com Headlines - Category: Radiology Authors: Tags: Womens Imaging Breast Imaging RSNA 2023 Source Type: news